## Gene Summary
The gene GNB3 encodes the guanine nucleotide-binding protein subunit beta-3, which is a member of the G protein family. G proteins are involved in transmitting chemical signals from the outside of a cell to the inside. GNB3 is ubiquitously expressed in various tissues, with a crucial role in signal transduction pathways that regulate cellular responses to hormones, neurotransmitters, and other stimuli. The encoded protein forms a dimer with G protein gamma subunits, influencing various downstream effectors and playing a pivotal role in the modulation of cellular signaling.

## Gene Drugs, Diseases, Phenotypes, and Pathways
GNB3 has been linked to a variety of diseases and phenotypes mainly due to its wide-ranging effects in cell signal transduction. Variants in this gene have been associated with obesity, hypertension, depression, and certain cardiac conditions. This gene's protein product is involved in pathways relating to G-protein coupled receptor signaling, which affect cardiovascular functions, neurotransmitter processes and metabolic pathways. The diverse roles of GNB3 in these fundamental pathways underscore its potential impact on multiple phenotypes and disease states.

## Pharmacogenetics
The pharmacogenetic implications of GNB3 are notable, particularly concerning cardiovascular diseases and treatment responses. Specifically, the C825T polymorphism in the GNB3 gene is well-studied and has been associated with differing responses to antihypertensive drugs. Individuals carrying specific variants of this SNP may exhibit differentiated therapeutic outcomes when treated with certain beta-blockers or calcium channel blockers, suggesting that GNB3 genotyping could help in tailoring hypertension management strategies. Furthermore, its pharmacogenetic relevance extends into the treatment of depression, where GNB3 expression might influence the efficacy of certain antidepressants, although more specific drug interactions are still under research.